Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuroprotective Effect of High Dose Erythropoietin in Very Preterm Infants

NCT00413946 is registered in ClinicalTrials.gov with Swiss Neonatal Network as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00413946 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuroprotective Effect of High Dose Erythropoietin in Very Preterm Infants
Lead sponsor
Swiss Neonatal Network
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2006
Completion date
December 31, 2012
Enrollment
420 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral palsy, developmental psychomotor disorders, intracranial hemorrhage, periventricular leukomalacia